179 related articles for article (PubMed ID: 16834554)
1. Drug-eluting bioresorbable stents for various applications.
Zilberman M; Eberhart RC
Annu Rev Biomed Eng; 2006; 8():153-80. PubMed ID: 16834554
[TBL] [Abstract][Full Text] [Related]
2. Approaches for prevention of restenosis.
Kraitzer A; Kloog Y; Zilberman M
J Biomed Mater Res B Appl Biomater; 2008 May; 85(2):583-603. PubMed ID: 18098192
[TBL] [Abstract][Full Text] [Related]
3. [The bioresorbable coronary scaffold].
Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
[TBL] [Abstract][Full Text] [Related]
4. Polymers, drug release, and drug-eluting stents.
Commandeur S; van Beusekom HM; van der Giessen WJ
J Interv Cardiol; 2006 Dec; 19(6):500-6. PubMed ID: 17107364
[TBL] [Abstract][Full Text] [Related]
5. Engineering aspects of stents design and their translation into clinical practice.
Sangiorgi G; Melzi G; Agostoni P; Cola C; Clementi F; Romitelli P; Virmani R; Colombo A
Ann Ist Super Sanita; 2007; 43(1):89-100. PubMed ID: 17536159
[TBL] [Abstract][Full Text] [Related]
6. Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.
Kraak RP; Grundeken MJ; Koch KT; de Winter RJ; Wykrzykowska JJ
Expert Rev Med Devices; 2014 Sep; 11(5):467-80. PubMed ID: 25087771
[TBL] [Abstract][Full Text] [Related]
7. Coronary stents: historical development, current status and future directions.
Iqbal J; Gunn J; Serruys PW
Br Med Bull; 2013; 106():193-211. PubMed ID: 23532779
[TBL] [Abstract][Full Text] [Related]
8. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
Waksman R; Pakala R
EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stents: a multidisciplinary success story.
Burt HM; Hunter WL
Adv Drug Deliv Rev; 2006 Jun; 58(3):350-7. PubMed ID: 16546288
[TBL] [Abstract][Full Text] [Related]
10. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
[TBL] [Abstract][Full Text] [Related]
11. Bioresorbable scaffolds in peripheral arterial disease.
Kassimis G; Spiliopoulos S; Katsanos K; Tsetis D; Krokidis ME
Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):443-50. PubMed ID: 24650312
[TBL] [Abstract][Full Text] [Related]
12. Bioresorbable drug-eluting scaffolds for treatment of vascular disease.
Suwannasom P; Sotomi Y; Tateishi H; Tenekecioglu E; Zeng Y; Kraak RP; Wykrzykowska JJ; De Winter RJ; Serruys PW; Onuma Y
Expert Opin Drug Deliv; 2016; 13(5):725-39. PubMed ID: 26865247
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
14. Local drug delivery for treatment of coronary and peripheral artery disease.
Gertz ZM; Wilensky RL
Cardiovasc Ther; 2011 Dec; 29(6):e54-66. PubMed ID: 20553281
[TBL] [Abstract][Full Text] [Related]
15. Bioresorbable polymeric stents: current status and future promise.
Eberhart RC; Su SH; Nguyen KT; Zilberman M; Tang L; Nelson KD; Frenkel P
J Biomater Sci Polym Ed; 2003; 14(4):299-312. PubMed ID: 12747671
[TBL] [Abstract][Full Text] [Related]
16. New generation coronary stent technology--is the future biodegradable?
Sammel AM; Chen D; Jepson N
Heart Lung Circ; 2013 Jul; 22(7):495-506. PubMed ID: 23548335
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.
Kandzari DE; Tcheng JE; Zidar JP
Catheter Cardiovasc Interv; 2002 Aug; 56(4):562-76. PubMed ID: 12124974
[TBL] [Abstract][Full Text] [Related]
18. [Bioresorbable scaffolds - nobody is perfect (yet)].
Alibegovic Zaza J; Zaza S
Rev Med Suisse; 2015 Mar; 11(464):546, 548-52. PubMed ID: 25924249
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
20. Bioresorbable polystatin fourth-generation stents.
Kaesemeyer WH; Sprankle KG; Kremsky JN; Lau W; Helmus MN; Ghatnekar GS
Coron Artery Dis; 2013 Sep; 24(6):516-21. PubMed ID: 23863781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
